Usha Sethuraman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Usha Sethuraman has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Meghna Shukla
College of Nursing, Wayne State University
2 shared publications - Aaron Brody
Wayne State University School of Medicine, Detroit, MI
1 shared publication - Ahmad Charaf Eddine
Division of Cardiology
1 shared publication - Ahmad Farooqi
Children’s Hospital of Michigan Clinical Research Institute, Assistant Professor of Biostatistics Central Michigan University, Detroit, MI
1 shared publication - Ahmad Farooqi
Children’s Research Center of MI, Wayne State University School of Medicine, Detroit, MI 48201, USA
1 shared publication - Amy D. Thompson
Clinical Pediatrics, Division of Emergency Medicine, Nemours Children’s Hospital, Sydney Kimmel Medical College of Thomas Jefferson University, Wilmington, USA
1 shared publication
Latest Publications
- 10 March 2026
- Published by Elsevier in Resuscitation
- p. 111048
Effect of prehospital respiratory interventions on pediatric drowning outcomes
- 10 March 2026
- Published by Elsevier in Resuscitation
- p. 111048
Effect of prehospital respiratory interventions on pediatric drowning outcomes
- 1 January 2022
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 51, 13-21
Bicycle handlebar injuries – a systematic review of pediatric chest and abdominal injuries
- 1 January 2022
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 51, 13-21
Bicycle handlebar injuries – a systematic review of pediatric chest and abdominal injuries
- 1 November 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 49, 291-293
Thrombosis of external iliac and common femoral arteries secondary to blunt trauma due to handlebar injury
- 1 November 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 49, 291-293
Thrombosis of external iliac and common femoral arteries secondary to blunt trauma due to handlebar injury
- 1 July 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 45, 71-74
Pediatric minor head injury related return visits to the emergency department and their outcome
- 1 July 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 45, 71-74
Pediatric minor head injury related return visits to the emergency department and their outcome
- 16 January 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 180 (5) , 1581-1591
SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment
This study was conducted to assess the clinical spectrum, management, and outcome of SARS-CoV-2-related multisystem inflammatory syndrome in children (MIS-C). We reviewed medical records of children with MIS-C diagnosis seen at the Children’s Hospital of Michigan in Detroit between April and June 2020. Thirty-three children were identified including 22 who required critical care (group 1) and 11 with less intense inflammation (group 2). Children in group 1 were older (median 7.0 years) than those in group 2 (median 2.0 years). Abdominal pain was present in 68% of patients in group 1. Hypotension or shock was present in 17/22 patients in group 1. Thirteen (39.4%) had Kawasaki disease (KD)–like manifestations. Five developed coronary artery dilatation; All resolved on follow-up. Intravenous immunoglobulin (IVIG) was given to all patients in group 1 and 7/11 in group 2. Second-line therapy was needed in 13/22 (group 1) for persisting inflammation or myocardial dysfunction; 12 received infliximab. All patients recovered. Conclusion: MIS-C clinical manifestations may overlap with KD; however, MIS-C is likely a distinct inflammatory process characterized by reversible myocardial dysfunction and rarely coronary artery dilatation. Supportive care, IVIG, and second-line therapy with infliximab were associated with a favorable outcome. What is Known: • Multisystem inflammatory syndrome in children (MIS-C) manifestations include fever, gastrointestinal symptoms, shock, and occasional features of Kawasaki disease (KD). • Treatment includes immunomodulatory agents, most commonly IVIG and corticosteroids. What is New: • Spectrum of MIS-C varies from mild to severe inflammation and coronary artery dilatation occurred in 5/22 (23%) critically ill patients. • IVIG and infliximab therapy were associated with a favorable outcome including resolution of coronary dilatation; only 2/33 received corticosteroids.
- 16 January 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 180 (5) , 1581-1591
SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment
This study was conducted to assess the clinical spectrum, management, and outcome of SARS-CoV-2-related multisystem inflammatory syndrome in children (MIS-C). We reviewed medical records of children with MIS-C diagnosis seen at the Children’s Hospital of Michigan in Detroit between April and June 2020. Thirty-three children were identified including 22 who required critical care (group 1) and 11 with less intense inflammation (group 2). Children in group 1 were older (median 7.0 years) than those in group 2 (median 2.0 years). Abdominal pain was present in 68% of patients in group 1. Hypotension or shock was present in 17/22 patients in group 1. Thirteen (39.4%) had Kawasaki disease (KD)–like manifestations. Five developed coronary artery dilatation; All resolved on follow-up. Intravenous immunoglobulin (IVIG) was given to all patients in group 1 and 7/11 in group 2. Second-line therapy was needed in 13/22 (group 1) for persisting inflammation or myocardial dysfunction; 12 received infliximab. All patients recovered. Conclusion: MIS-C clinical manifestations may overlap with KD; however, MIS-C is likely a distinct inflammatory process characterized by reversible myocardial dysfunction and rarely coronary artery dilatation. Supportive care, IVIG, and second-line therapy with infliximab were associated with a favorable outcome. What is Known: • Multisystem inflammatory syndrome in children (MIS-C) manifestations include fever, gastrointestinal symptoms, shock, and occasional features of Kawasaki disease (KD). • Treatment includes immunomodulatory agents, most commonly IVIG and corticosteroids. What is New: • Spectrum of MIS-C varies from mild to severe inflammation and coronary artery dilatation occurred in 5/22 (23%) critically ill patients. • IVIG and infliximab therapy were associated with a favorable outcome including resolution of coronary dilatation; only 2/33 received corticosteroids.
- Open Access
- 19 May 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (5) , 1531
Urinary Tract Infection in Febrile Children with Sickle Cell Disease Who Present to the Emergency Room with Fever
Sickle cell disease (SCD) patients are thought to be at higher risk for urinary tract infections (UTIs) compared to the general population secondary to increased sickling, abnormal urinary acidification, and an inability to concentrate the urine. The incidence of UTI in febrile children with SCD in the United States is unknown. Our objectives were to determine the rate of UTI among febrile SCD children and describe the risk factors for UTI in this population. We conducted a retrospective chart review of all febrile SCD patients <4 years of age who presented to a pediatric emergency department from 2012–2017 and who had a sterile sample of urine for analysis. A total of 167 febrile patients with SCD with 464 visits were identified. The majority were African American (95.2%), female (58.7%), and had hemoglobin SS (HbSS) (65.3%). The rate of UTI was 4.1%. All patients with a UTI were African American females with a median age of 19 months (IQR 12–30). On regression analysis, no risk factors were associated with a UTI. We found the rate of UTI in febrile young children with SCD was comparable to non-SCD children. Larger studies are required to identify the presence of risk factors for UTI in this population.
- 19 May 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (5) , 1531
Open AccessUrinary Tract Infection in Febrile Children with Sickle Cell Disease Who Present to the Emergency Room with Fever
Sickle cell disease (SCD) patients are thought to be at higher risk for urinary tract infections (UTIs) compared to the general population secondary to increased sickling, abnormal urinary acidification, and an inability to concentrate the urine. The incidence of UTI in febrile children with SCD in the United States is unknown. Our objectives were to determine the rate of UTI among febrile SCD children and describe the risk factors for UTI in this population. We conducted a retrospective chart review of all febrile SCD patients <4 years of age who presented to a pediatric emergency department from 2012–2017 and who had a sterile sample of urine for analysis. A total of 167 febrile patients with SCD with 464 visits were identified. The majority were African American (95.2%), female (58.7%), and had hemoglobin SS (HbSS) (65.3%). The rate of UTI was 4.1%. All patients with a UTI were African American females with a median age of 19 months (IQR 12–30). On regression analysis, no risk factors were associated with a UTI. We found the rate of UTI in febrile young children with SCD was comparable to non-SCD children. Larger studies are required to identify the presence of risk factors for UTI in this population.
- Open Access
- 8 April 2019
- Published by Springer Nature in Israel Journal of Health Policy Research
- Vol. 8 (1) , 35
Optimizing the treatment of pain and anxiety in pediatric emergencies: the role of accreditation
Pervasive disparities exist in the treatment of pain and anxiety in pediatric patients presenting to hospitals with emergency conditions. This finding has been demonstrated worldwide, and is especially exacerbated in general emergency departments, which treat both adults and children. Policies to promote appropriate analgesia in the context of pediatric emergency care have been developed by several professional societies and governmental agencies in the United States; however, progress has been uneven, and data regarding these questions is lacking. In their excellent article, Capua and her co-authors address this precise problem through a unique methodology, by surveying nurse directors of both pediatric accredited and non-accredited emergency departments. Survey questions focused on availability of pharmacological and non-pharmacological modalities, and on the prevalence with which providers administered both oral and parenteral medications. The results demonstrated widespread availability of evidence based analgesic and anxiolytic treatment, ranging from medical clowns and specific holding positions, to use of intravenous opiates and conscious sedation. No significant differences were found associated with accreditation. These results are surprising and seem to call into question the value of pediatric accreditation. However, an alternative hypothesis would be that accreditation has succeeded, and the results reflect a large spillover effect, in which providers trained in accredited institutions bring these advanced practices to their local departments. Regionalization has been promoted for emergency care of many acute conditions such as trauma, stroke, and myocardial infarction. These results suggest that for pediatric emergencies, at least in regard to analgesia, the answer likely lies in dissemination of knowledge, rather than super specialization. In other words, bring the expertise to the children, not the children to the experts. Further research in this area could focus on optimal ways to achieve such knowledge translation.
- 8 April 2019
- Published by Springer Nature in Israel Journal of Health Policy Research
- Vol. 8 (1) , 35
Open AccessOptimizing the treatment of pain and anxiety in pediatric emergencies: the role of accreditation
Pervasive disparities exist in the treatment of pain and anxiety in pediatric patients presenting to hospitals with emergency conditions. This finding has been demonstrated worldwide, and is especially exacerbated in general emergency departments, which treat both adults and children. Policies to promote appropriate analgesia in the context of pediatric emergency care have been developed by several professional societies and governmental agencies in the United States; however, progress has been uneven, and data regarding these questions is lacking. In their excellent article, Capua and her co-authors address this precise problem through a unique methodology, by surveying nurse directors of both pediatric accredited and non-accredited emergency departments. Survey questions focused on availability of pharmacological and non-pharmacological modalities, and on the prevalence with which providers administered both oral and parenteral medications. The results demonstrated widespread availability of evidence based analgesic and anxiolytic treatment, ranging from medical clowns and specific holding positions, to use of intravenous opiates and conscious sedation. No significant differences were found associated with accreditation. These results are surprising and seem to call into question the value of pediatric accreditation. However, an alternative hypothesis would be that accreditation has succeeded, and the results reflect a large spillover effect, in which providers trained in accredited institutions bring these advanced practices to their local departments. Regionalization has been promoted for emergency care of many acute conditions such as trauma, stroke, and myocardial infarction. These results suggest that for pediatric emergencies, at least in regard to analgesia, the answer likely lies in dissemination of knowledge, rather than super specialization. In other words, bring the expertise to the children, not the children to the experts. Further research in this area could focus on optimal ways to achieve such knowledge translation.
- 24 March 2016
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 63 (2) , 303-315
ABCs of Safety and Quality for the Pediatric Resident and Fellow
- 24 March 2016
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 63 (2) , 303-315
ABCs of Safety and Quality for the Pediatric Resident and Fellow